BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The 3rd Targeted Radiopharmaceuticals (TRP) Summit returns at 
 a crucial time for the entire industry. Spurred on by positive Phase III 
 VISION trial data\, there has been huge research investment\, on both sid
 es of the Atlantic\, on how to deliver radiation therapy directly and spe
 cifically to tumours.\n\nFor the 2021 edition of this conference\, there 
 will be the opportunity to attend either in-person in Berlin or remotely 
 via a dedicated digital networking platform with all the access to the co
 nference content.\n\nYou can expect a wider array of insights from recent
  case studies to help you accelerate the development of the next generati
 on of radioligand therapies from clinical approval to commercialisation.\
 n\nAs the only industry-led platform for discussing challenges and opport
 unities facing developers of theranostic radioligand therapies\, we striv
 e to tackle topics that are on every drug developer’s mind:\n\nHow do we 
 identify and validate new targets?Can we combine Targeted Radiopharmaceut
 icals with immunotherapy or other targeted oncology methods?How do we imp
 rove current clinical design methodologies and patient selection strategi
 es?Where can improvements be made to the current supply and fulfilment mo
 dels?\n
DTEND:20211209T170000
DTSTAMP:20260512T220029Z
DTSTART:20211207T090000
LOCATION:Hilton Berlin\, 30\, Mohrenstraße\, Berlin\, \, 10117\,
SEQUENCE:0
SUMMARY:The 3rd Targeted Radiopharmaceuticals (TRP) Summit returns at a cr
 ucial time for the entire industry. Spurred on by positive Phase III VISI
 ON trial...
UID:fe7d20f8-c08f-460e-946c-b7be07d85b07
END:VEVENT
END:VCALENDAR